Cor Vasa 2015, 57(1):e16-e27 | DOI: 10.1016/j.crvasa.2014.12.004
Twenty years of alcohol septal ablation document more than a history of a single interventional procedure
- Kardiologická klinika, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice v Motole, Praha, Česká republika
The first alcohol septal ablation (ASA) was performed in 1994. The concept of "therapeutic acute myocardial infarction" caused by application of concentrated alcohol into coronary artery is not quite unique since certain arrhythmias were treated in a similar way in the past; however, ASA has been discussed widely since its introduction and refused for many years by many cardiologists. Sufficiently robust data from long-term follow-up of patients with hypertrophic obstructive cardiomyopathy treated with ASA were obtained in the past few years only, demonstrating the safety and long-term efficacy of ASA. This article deals with a history of the above-mentioned interventional procedure, its indications, technical aspects, safety, and long-term results.
Keywords: Ablation; Alcohol; Hypertrophic cardiomyopathy
Received: November 24, 2014; Accepted: December 3, 2014; Published: February 1, 2015 Show citation
References
- B.J. Gersh, B.J. Maron, R.O. Bonow, et al., 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy, Circulation 124 (2011) e783-e831.
Go to original source...
Go to PubMed...
- B.J. Maron, W.J. McKenna, G.K. Danielson, et al., American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy, European Heart Journal 24 (2003) 1965-1991.
Go to original source...
- D. Zemánek, P. Tomašov, S. Homolová, et al., Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy, European Journal of Echocardiography 12 (2011) 684-687.
Go to original source...
Go to PubMed...
- P. Sorajja, S.R. Ommen, R.A. Nishimura, Symptomatic obstructive hypertrophic cardiomyopathy, Circulation: Cardiovascular Interventions 6 (2013) 586-591.
Go to original source...
Go to PubMed...
- D. Teare, Asymmetrical hypertrophy of the heart in young adults, British Heart Journal 20 (1958) 1-8.
Go to original source...
- I. Olivotto, B. Tomberli, R. Spoladore, et al., Hypertrophic cardiomyopathy: the need for randomized trials, Global Cardiology Science and Practice 31 (2013), http://dx.doi.org/10.5339/gcsp.2013.31.
Go to original source...
Go to PubMed...
- J.W. Kirklin, F.H. Ellis Jr., Surgical relief of diffuse subvalvular aortic stenosis, Circulation 24 (1961) 739-742.
Go to original source...
- A.G. Morrow, E.C. Brockenbrough, Surgical treatment of idiopathic hypertrophic subaortic stenosis: technique and hemodynamic results of subaortic ventriculomyotomy, Annals of Surgery 154 (1961) 181-189.
Go to original source...
- S.R. Ommen, B.J. Maron, I. Olivotto, et al., Long-term effect of surgical myectomy on survival in patients with hypertrophic cardiomyopathy, Journal of the American College of Cardiology 46 (2005) 470-476.
Go to original source...
Go to PubMed...
- J. Veselka, T. Lawrenz, C. Stellbrink, et al., Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a European multicenter and multinational study, Catheterization and Cardiovascular Interventions 84 (2014) 101-107.
Go to original source...
Go to PubMed...
- B.J. Maron, Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy, Lancet 355 (2000) 425-426.
Go to original source...
Go to PubMed...
- U. Sigwart, Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy, Lancet 346 (1995) 211-214.
Go to original source...
- H.J. Kuhn, The history of alcohol septal ablation, Cardiovascular Revascularization Medicine 11 (2010) 260-261.
Go to original source...
Go to PubMed...
- F. Gietzen, C. Leuner, T. Gerenkamp, H. Kuhn, Abnahme der Obstruktion bei hypertrophischer Kardiomyopathie wahrend passage Okklusion des ersten Septalastes der linken Koronararterie, Zeitschrift für Kardiologie 83 (Suppl. 1) (1994) 146.
Go to PubMed...
- P. Brugada, H. de Swart, J.L. Smeets, H. Wellens, Transcoronary chemical ablation of ventricular tachycardia, Circulation 79 (1989) 475-482.
Go to original source...
- J.F. Goodwin, C.M. Oakley, Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy, Lancet 346 (1995) 1624.
Go to original source...
- U. Sigwart, Author's reply, Lancet 346 (1995) 1624.
Go to original source...
- J. Januška, J. Veselka, D. Tesař, et al., První zkušenosti s perkutánní transluminální septální myokardiální ablací, Cor et Vasa 40 (1998) 302-303.
- M.A. Fifer, U. Sigwart, Hypertrophic obstructive cardiomyopathy: alcohol septal ablation, European Heart Journal 32 (2012) 1059-1064.
Go to original source...
Go to PubMed...
- J. Veselka, Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature, Medical Science Monitor 13 (2007) RA62-RA68.
Go to original source...
- M. Alam, H. Dokainish, N.M. Lakkis, Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. A systematic review of literature, Journal of Interventional Cardiology 19 (2006) 319-327.
Go to original source...
Go to PubMed...
- M.S. Maron, I. Olivotto, S. Betocchi, et al., Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy, New England Journal of Medicine 348 (2003) 295-303.
Go to original source...
Go to PubMed...
- J.B. Geske, P. Sorajja, S.R. Ommen, R.A. Nishimura, Left ventricular outflow tract variability in hypertrophic cardiomyopathy, Clinical Cardiology 32 (2009) 397-402.
Go to original source...
Go to PubMed...
- C. Cotrim, P.P. Dimitrow, T.O. Cheng, Exercise echocardiography in hypertrophic cardiomyopathy: is upright evaluation needed after all? Revista Espanola de Cardiologia 66 (2013) 513-514.
Go to original source...
Go to PubMed...
- J. Veselka, T. Lawrenz, C. Stellbrink, et al., Low incidence of procedure-related major adverse cardiac events after alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy, Canadian Journal of Cardiology 29 (2013) 1415-1421.
Go to original source...
Go to PubMed...
- J. Veselka, D. Zemánek, P. Tomašov, et al., Complications of low-dose, echo-guided alcohol septal ablation, Catheterization and Cardiovascular Interventions 75 (2010) 546-550.
Go to original source...
- M.S. Maron, I. Olivotto, C. Harrigan, et al., Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy, Circulation 124 (2011) 40-47.
Go to original source...
Go to PubMed...
- P. Angelini, C. Uribe, J. Monge, et al., Apical hypertrophic cardiomyopathy: preliminary attempt at palliation with use of subselective alcohol ablation, Texas Heart Institute Journal 39 (2012) 750-755.
Go to PubMed...
- H. Seggewiss, L. Faber, Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction, European Journal of Echocardiography 1 (2000) 277-280.
Go to original source...
Go to PubMed...
- L. Faber, H. Seggewiss, U. Gleichmann, Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography, Circulation 98 (1998) 2415-2421.
Go to original source...
- H. Kuhn, F. Gietzen, C. Leuner, T. Gerenkamp, Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment, European Heart Journal 18 (1997) 846-851.
Go to original source...
- H. Kuhn, T. Lawrenz, F. Lieder, et al., Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience, Clinical Research in Cardiology 97 (2008) 234-243.
Go to original source...
Go to PubMed...
- J. Veselka, D. Zemanek, P. Tomasov, et al., Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective, Heart and Vessels 24 (2009) 27-31.
Go to original source...
Go to PubMed...
- J. Veselka, R. Duchonova, S. Prochazkova, et al., Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes, American Journal of Cardiology 95 (2005) 675-678.
Go to original source...
Go to PubMed...
- J. Veselka, P. Tomašov, D. Zemánek, Long-term effects of varying alcohol dosing in percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a randomized study with a follow-up up to 11 years, Canadian Journal of Cardiology 27 (2011) 763-767.
Go to original source...
Go to PubMed...
- J. Veselka, Š. Procházková, R. Duchoňová, et al., Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome, Catheterization and Cardiovascular Interventions 64 (2004) 231-235.
Go to original source...
Go to PubMed...
- J. Veselka, R. Duchoňová, J. Páleníčková, et al., Impact of ethanol dosing on long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a single-center, prospective, and randomized study, Circulation Journal 70 (2006) 1550-1552.
Go to original source...
Go to PubMed...
- J. Veselka, J. Krejčí, P. Tomašov, et al., Survival of patients after alcohol septal ablation for hypertrophic obstructive cardiomyopathy ≤50 years of age, Canadian Journal of Cardiology 30 (2014) 634-638.
Go to original source...
Go to PubMed...
- A. Almasood, P. Garceau, A. Woo, et al., Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy, JACC Cardiovascular Interventions 4 (2011) 1030-1034.
Go to original source...
Go to PubMed...
- S.F. Nagueh, N.M. Lakkis, Z.X. He, et al., Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy, Journal of the American College of Cardiology 32 (1998) 225-229.
Go to original source...
Go to PubMed...
- J. Veselka, D. Zemánek, J. Fiedler, P. Šváb, Real-time myocardial contrast echocardiography for echo-guided alcohol septal ablation, Archives of Medical Science 5 (2009) 271-272.
- L. Faber, H. Seggewiss, D. Fassbender, et al., Guiding interventional myocardial ablation in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography: first experience, in: 8th Essen-Mayo-Mainz Symposium, October 25-27, 1996.
- M.A. Fifer, D.M. Yoerger, M.H. Picard, et al., Covered stent septal ablation for hypertrophic obstructive cardiomyopathy: initial success but ultimate failure resulting from collateral formation, Circulation 107 (2003) 3248-3249.
Go to original source...
Go to PubMed...
- C.M. Gross, J. Schulz-Menger, J. Kramer, et al., Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes, Journal of Endovascular Therapy 11 (2004) 705-711.
Go to original source...
Go to PubMed...
- A. Oto, K. Aytemir, A. Deniz, New approach to septal ablation: glue (cyanoacrylate) septal ablation, Catheterization and Cardiovascular Interventions 69 (2007) 1021-1025.
Go to original source...
Go to PubMed...
- E. Durand, E. Mousseaux, P. Coste, et al., Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6-month follow-up, European Heart Journal 29 (2008) 348-355.
Go to original source...
Go to PubMed...
- M. Špaček, D. Zemánek, P. Tomašov, J. Veselka, Early opening of dormant septal collaterals during alcohol septal ablation: a possible hazard of remote necrosis, Canadian Journal of Cardiology 29 (2013) 1531.e5-e7.
Go to original source...
Go to PubMed...
- L. Riedlbauchova, J. Janousek, J. Veselka, Ablation of hypertrophic septum using radiofrequency energy - an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy?, Journal of Invasive Cardiology 25 (2013) E128-E132.
Go to PubMed...
- T. Lawrenz, B. Borchert, C. Leuner, et al., Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6-month follow-up in 19 patients, Journal of the American College of Cardiology 57 (2001) 572-576.
Go to original source...
- J. Veselka, J. Krejci, P. Tomasov, et al., Outcome of patients after alcohol septal ablation with permanent pacemaker implanted for periprocedural complete heart block, International Journal of Cardiology 171 (2014) e37-e38.
Go to original source...
Go to PubMed...
- T. Lawrenz, F. Lieder, M. Bartelsmeier, et al., Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy, Journal of the American College of Cardiology 49 (2007) 2356-2363.
Go to original source...
Go to PubMed...
- J.J. Wykrzykowska, K. Kwaku, J. Wylie, et al., Delayed occurrence of unheralded phase IV complete heart block after ethanol septal ablation for symmetric hypertrophic obstructive cardiomyopathy, Pace 29 (2006) 674-678.
Go to original source...
Go to PubMed...
- A.A. Chen, I.F. Palacios, T. Mela, et al., Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy, American Journal of Cardiology 97 (2006) 264-269.
Go to original source...
Go to PubMed...
- R. Poyet, J. Quilisi, T. Cuisset, et al., Delayed occurrence of complete heart block after ethanol septal ablation for hypertrophic obstructive cardiomyopathy, International Journal of Cardiology 147 (2011) e32-e34.
Go to original source...
Go to PubMed...
- S.S. El-Jack, M. Nasif, J.W. Blake, et al., Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation, Journal of Interventional Cardiology 20 (2007) 73-76.
Go to original source...
Go to PubMed...
- S.M. Chang, S.F. Nagueh, W.H. Spencer, N.M. Lakkis, Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy, Journal of the American College of Cardiology 42 (2003) 296-300.
Go to original source...
Go to PubMed...
- J. Veselka, Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: focus on safety, Swiss Medical Weekly 137 (2007) 657-659.
Go to original source...
Go to PubMed...
- J. Veselka, Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: is it safe? Catheterization and Cardiovascular Interventions 74 (2009) 520-521.
Go to original source...
Go to PubMed...
- R.D. Simon, F.A. Crawford, W.H. Spencer, M.R. Gold, Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy, Pacing and Clinical Electrophysiology 28 (2005) 1354-1356.
Go to original source...
Go to PubMed...
- J. Veselka, R. Duchonová, S. Procházková, et al., The biphasic course of changes of left ventricular outflow gradient after alcohol septal ablation for hypertrophic obstructive cardiomyopathy, Kardiologia Polska 60 (2004) 133-136.
Go to PubMed...
- D.M. Yoerger, M.H. Picard, I.F. Palacios, et al., Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy, American Journal of Cardiology 97 (2006) 1511-1514.
Go to original source...
Go to PubMed...
- W. Mazur, S.F. Nagueh, N.M. Lakkis, et al., Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy, Circulation 103 (2001) 1492-1496.
Go to original source...
- J. Veselka, Pressure gradient response after alcohol septal ablation in hypertrophic obstructive cardiomyopathy, Kardiologia Polska 64 (2006) 1161-1162.
Go to original source...
Go to PubMed...
- B.J. Maron, E.J. Rowin, S.A. Casey, et al., Risk stratification and outcome of patients with hypertrophic cardiomyopathy ≥60 years of age, Circulation 127 (2013) 585-593.
Go to original source...
Go to PubMed...
- B.J. Maron, P. Spirito, M.J. Ackermann, et al., Prevention of sudden cardiac death with implantable cardioverterdefibrillator in children and adolescents with hypertrophic cardiomyopathy, Journal of the American College of Cardiology 61 (2013) 1527-1535.
Go to original source...
Go to PubMed...
- J. Veselka, R. Duchonova, J. Palenickova, et al., Age-related hemodynamic and morphologic differences in patients undergoing alcohol septal ablation for hypertrophic obstructive cardiomyopathy, Circulation Journal 70 (2006) 880-884.
Go to original source...
Go to PubMed...
- R.A. Leonardi, J.C. Townsend, C.A. Patel, et al., Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: outcomes in young, middle-aged, and elderly patients, Catheterization and Cardiovascular Interventions 82 (2013) 838-845.
Go to original source...
Go to PubMed...
- J. Veselka, P. Tomašov, D. Zemánek, Mid-term outcomes of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in patients with sigmoid versus neutral ventricular septum, Journal of Invasive Cardiology 24 (2012) 636-640.
Go to original source...
- D.S. Jassal, T.G. Neilan, M.A. Fifer, et al., Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy, European Heart Journal 27 (2006) 1805-1810.
Go to original source...
Go to PubMed...
- J. Veselka, Improvement of left ventricular diastolic function after alcohol septal ablation for obstructive hypertrophic cardiomyopathy? Yes, of course, but..., European Heart Journal 27 (2006) 2901-2902.
Go to original source...
Go to PubMed...
- P. Sorajja, R.A. Nishimura, S.R. Ommen, et al., Effect of septal ablation on myocardial relaxation and left atrial pressure in hypertrophic cardiomyopathy an invasive hemodynamic study, JACC Cardiovascular Interventions 1 (2008) 552-560.
Go to original source...
Go to PubMed...
- J. Veselka, Š. Procházková, R. Duchoňová, et al., Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: a mid-term follow-up, Echocardiography 22 (2005) 105-110.
Go to original source...
Go to PubMed...
- J. Veselka, T. Honěk, Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, International Journal of Cardiology 88 (2003) 27-32.
Go to original source...
- J. Veselka, J. Krejci, P. Tomasov, D. Zemanek, Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population, European Heart Journal 35 (2014) 2040-2045.
Go to original source...
Go to PubMed...
- L.A. Malek, L. Chojnowska, M. Klopotowski, et al., Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation, European Journal of Heart Failure 10 (2008) 1123-1126.
Go to original source...
Go to PubMed...
- B.J. Maron, M. Yacoub, J.A. Dearani, Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back to European patients, European Heart Journal 32 (2011) 1055-1058.
Go to original source...
Go to PubMed...
- B.J. Maron, Commentary and re-appraisal: surgical myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelines, Progress in Cardiovascular Diseases 54 (2012) 523-528.
Go to original source...
Go to PubMed...
- P. Sorajja, S.R. Ommen, D.R. Holmes Jr., et al., Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Circulation 16 (2012) 2374-2380.
Go to original source...
Go to PubMed...
- M.K. Jensen, C. Prinz, D. Horstkotte, et al., Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile, Heart 99 (2013) 1012-1017.
Go to original source...
Go to PubMed...
- L. Faber, H. Seggewiss, D. Welge, et al., Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience, European Journal of Echocardiography 5 (2004) 347-355.
Go to original source...
Go to PubMed...
- S.F. Nagueh, B.M. Groves, L. Schwartz, et al., Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry, Journal of the American College of Cardiology 58 (2011) 2322-2328.
Go to original source...
Go to PubMed...
- J. Veselka, Š. Procházková, R. Duchoňová, et al., Echocardiographic examination before alcohol septal ablation can predict residual pressure gradient, Cor et Vasa 46 (2004) 524-527.
- P. Sorajja, J. Binder, R.A. Nishimura, et al., Predictors of an optimal clinical outcome with alcohol septal ablation for hypertrophic obstructive cardiomyopathy, Catheterization and Cardiovascular Interventions 81 (2013) E57-E68.
Go to original source...
Go to PubMed...